Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank93
3Y CAGR+82.6%
5Y CAGR+44.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+82.6%/yr
vs +7.6%/yr prior
5Y CAGR
+44.8%/yr
Recent acceleration
Acceleration
+75.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
6.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.67M | -11.7% |
| 2024 | $24.54M | +42.1% |
| 2023 | $17.27M | +385.7% |
| 2022 | $3.56M | +572.4% |
| 2021 | $529000.00 | -84.4% |
| 2020 | $3.40M | -32.9% |
| 2019 | $5.07M | +90.8% |
| 2018 | $2.66M | +5522.4% |
| 2017 | $-49000.00 | +97.6% |
| 2016 | $-2.04M | - |